Nuclera
@nuclera
Followers
708
Following
116
Media
38
Statuses
238
Revolutionizing protein access at the benchtop.
Cambridge, England
Joined October 2013
Sign up today for 26th July webinar, to hear CTO Gordon McInroy PhD discuss rapid active protein access using the eProtein Discovery system https://t.co/n4ziE1x2IN
#proteinexpression #solubleprotein
nuclera.com
In this webinar, Gordon McInroy PhD, Chief Technology Officer and Co-founder of Nuclera, will explore the latest developments in protein expression.
0
3
7
We are honored and delighted to welcome synthetic biology leader Professor Michael Jewett as a distinguished member to our Scientific Advisory Board! Dr. Jewett brings Nuclera subject matter expertise on harnessing cell free protein synthesis technologies https://t.co/JFsGtzriU5
0
0
3
We're delighted to announce that we received the @businessweekly Tech Scale-up of the Year Award. 2022 has brought our eProtein bioprinter into select labs enabling their access to proteins which is a key milestone on our path to our launch. https://t.co/jUE6eCeW3r
0
0
7
Welcome to @synsenso_eu - a new @mscactions doctoral network led by @synbiocentre @tudarmstadt, set out to develop new combinatorial #biosensors. Visit our website to find out more 👇 @HorizonEU #MSCA #DN 🧬
0
4
12
We are so thrilled to have Dr. Colin Barnes on our Executive Leadership Team as our VP of Intellectual Property. Read more about Colin's career and his pivotal role in the commercialization of early sequencing technology. https://t.co/ApsFjsZ0Gj
illumina.com
An inventor and Solexa co-founder talks about the early days of sequencing technology
0
0
1
Proteins are key for drug discovery. The startup @nuclera has worked on bringing a desktop 3D protein printer to market since 2013, to help scientists do their research. Now with a €38m raise, it can do it. @AmadeusCapital @EInk #Biotechnology @siftedeu
0
6
21
Nuclera raises $42.5M in first close of Series B for desktop protein printer
0
1
4
Nuclera announces expansion with new US subsidiary https://t.co/JNI9JERqqs
#desktopbioprinting #makebiologyaccessible
1
0
3
We are #expanding! Check out a range of job openings in #software, #finance, #engineering and #biology. See how you can help us launch our desktop bioprinter: https://t.co/8sGzuoFaZv
apply.workable.com
Nuclera is a more than 100 person strong, fast-growing biotech company based in UK and USA. We are building the world'd first desktop bioprinter capable of printing proteins overnight.
0
1
3
🧬🔬👍👍
Tired of the endless cloning and protein expression experiments? Come and join our exciting team at @nuclera 🌟🌟 We are looking for a Synthetic Biologist to help developing our desktop bioprinter: DNA to proteins within a day 😱 https://t.co/P9QLHV4rMG
0
0
0
Warm congratulations to Prof Shankar Balasubramanian for winning the 2021 Breakthrough prize for next-generation sequencing. Shankar is a scientific mentor to our very own Michael & Gordon.
theguardian.com
Creators of next-generation genome sequencing take science’s most lucrative award
0
1
4
With the right team and today’s technology, there are no limitations. @Nuclera and @EInk have made biology accessible together through digital microfluidics.
blog.eink.com
Nuclera Desktop Bioprinter Powered by Digital Microfluidic Technology
0
1
3
We look forward to continuing our fruitful collaboration with @EInk to #makebiologyaccessible for all!
0
0
5
Now on Clubhouse, we have Michael Chen of @nuclera, which is combining enzymatic DNA synthesis, digital microfluidics, and protein synthesis in a desktop bioprinter. They are on a mission to make biology more accessible. Join the discussion now! #synbio
https://t.co/AqEXKwFgBT
0
3
5
Join us TODAY at 8 am PT for Built with Biology: Cheese and AI! Check out this week’s expert speakers: @KocerDilek and @CommsMattr of @motiffoodworks, @nikhitasingh of @Artificial__Inc and Michael Chen of @nuclera
#synbio #AI #plantbased
https://t.co/AqEXKwFgBT
0
2
2
We are excited to announce our partnership with @Eink to make #biology accessible through digital microfluidics! https://t.co/pY8VYzpnNa
1
2
8